The investigators show that "good" bacteria in the gut keep the immune system primed to more effectively fight infection from invading pathogenic bacteria. Altering the intricate dynamic between resident and foreign bacteria – via antibiotics, for example – compromises an animal’s immune response, specifically, the function of white blood cells called neutrophils.
Senior author Jeffrey Weiser, MD, professor of Microbiology and Pediatrics, likens these findings to starting a car: It's much easier to start moving if a car is idling than if its engine is cold. Similarly, if the immune system is already warmed up, it can better cope with pathogenic invaders. The implication of these initial findings in animals, he says, is that prolonged antibiotic use in humans may effectively throttle down the immune system, such that it is no longer at peak efficiency.
“Neutrophils are being primed by innate bacterial signals, so they are ready to go if a microbe invades the body," Weiser explains. "They are sort of 'idling', and the baseline system is already turned on."
Weiser and first author Thomas Clarke, PhD, a postdoctoral fellow in the Weiser lab, published their findings last week in Nature Medicine.
"One of the complications of antibiotic therapy is secondary infection," Weiser explains. "This is a huge problem in hospitals, but there hasn't been a mechanistic understanding of how that occurs. We suggest that if the immune system is on idle, and you treat someone with broad-spectrum antibiotics, then you turn the system off. The system is deprimed and will be less efficient at responding quickly to new infections."
The findings also provide a potential explanation for the anecdotal benefits of probiotic therapies because keeping your immune system primed by eating foods enhanced with "good" bacteria may help counteract the negative effects of sickness and antibiotics.
Researchers have for many years understood that most bacteria in the body are not "bad." In fact, humans (and mice) have a symbiotic relationship with their resident microbes that significantly impacts, among other things, metabolism and weight homeostasis. As shown in this study, microbes also affect the innate immune response, via the cellular protein Nod1.
Present within neutrophils, Nod1 is a receptor that recognizes parts of the cell wall of bacteria. Weiser and his colleagues found that neutrophils derived from mice engineered to lack Nod1 are less effective at killing two common pathogens, Streptococcus pneumoniae and Staphylococcus aureus, than neutrophils from mice that do express the receptor.
In addition, neutrophils from mice that were raised in a germ-free environment or on antibiotics were likewise diminished in their immune responses, but this effect was not permanent: Re-exposure of these mice to a conventional environment (that is, one containing normal bacteria) restored immune function.
The team provided evidence for a potential mechanism for these observations by showing that bacterial cell wall material could be detected in the blood of normal mice, and that it influences neutrophils in the bone marrow. Finally, the team demonstrated they could improve immune function by treating both antibiotic-treated mice and human neutrophils with the Nod1 ligand – a finding that suggests it may be possible to counter the adverse consequences of antibiotics in humans.
The study was funded by the US Public Health Service.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $3.6 billion enterprise.
Penn’s School of Medicine is currently ranked #3 in U.S. News & World Report’s survey of research-oriented medical schools, and is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $367.2 million awarded in the 2008 fiscal year.
Penn Medicine’s patient care facilities include:The Hospital of the University of Pennsylvania – the nation’s first teaching hospital, recognized as one of the nation’s top 10 hospitals by U.S. News & World Report.
Additional patient care facilities and services include Penn Medicine at Rittenhouse, a Philadelphia campus offering inpatient rehabilitation and outpatient care in many specialties; as well as a primary care provider network; a faculty practice plan; home care and hospice services; and several multispecialty outpatient facilities across the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2009, Penn Medicine provided $733.5 million to benefit our community.
Karen Kreeger | EurekAlert!
Flow of cerebrospinal fluid regulates neural stem cell division
22.05.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Chemists at FAU successfully demonstrate imine hydrogenation with inexpensive main group metal
22.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology